How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic

Gilead gains accelerated FDA approval for rare liver disease treatment

FDA lifts hold on BioNTech and MediLink's ADC trial After safety revisions

Breakthrough delivery system could transform Alzheimer’s treatment

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Breaking News: Lecanemab approved in UK but unavailable on NHS

Highlights

array(40) {
  [0]=>
  string(4) "1622"
  ["article_id"]=>
  string(4) "1622"
  [1]=>
  string(59) "Trained Alert Dogs Can Detect Impending T1DM-Related Events"
  ["article_title"]=>
  string(59) "Trained Alert Dogs Can Detect Impending T1DM-Related Events"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- Trained alert dogs can help patients with type 1 diabetes regulate their blood glucose levels, according to a study published"
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- Trained alert dogs can help patients with type 1 diabetes regulate their blood glucose levels, according to a study published"
  [3]=>
  string(254) "FRIDAY, Jan. 18, 2019 -- Trained alert dogs can help patients with type 1 diabetes regulate their blood glucose levels, according to a study published online Jan. 15 in PLOS ONE.&#nlNicola J. Rooney, Ph.D., from the University of Bristol in the United..."
  ["description"]=>
  string(254) "FRIDAY, Jan. 18, 2019 -- Trained alert dogs can help patients with type 1 diabetes regulate their blood glucose levels, according to a study published online Jan. 15 in PLOS ONE.&#nlNicola J. Rooney, Ph.D., from the University of Bristol in the United..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(200) "https://www.drugs.com/news/trained-alert-dogs-can-detect-impending-t1dm-related-events-79844.html?utm_source=ddc&utm_medium=rss&utm_campaign=Trained+Alert+Dogs+Can+Detect+Impending+T1DM-Related+Events"
  ["blog_url"]=>
  string(200) "https://www.drugs.com/news/trained-alert-dogs-can-detect-impending-t1dm-related-events-79844.html?utm_source=ddc&utm_medium=rss&utm_campaign=Trained+Alert+Dogs+Can+Detect+Impending+T1DM-Related+Events"
  [15]=>
  string(19) "2019-01-18 20:00:29"
  ["add_date"]=>
  string(19) "2019-01-18 20:00:29"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Trained Alert Dogs Can Detect Impending T1DM-Related Events

FRIDAY, Jan. 18, 2019 -- Trained alert dogs can help patients with type 1 diabetes regulate their blood glucose levels, 

array(40) {
  [0]=>
  string(4) "1623"
  ["article_id"]=>
  string(4) "1623"
  [1]=>
  string(50) "FDA Panel Has Tie Vote on New Type 1 Diabetes Drug"
  ["article_title"]=>
  string(50) "FDA Panel Has Tie Vote on New Type 1 Diabetes Drug"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for typ"
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for typ"
  [3]=>
  string(252) "FRIDAY, Jan. 18, 2019 -- A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for type 1 diabetes ended in an 8-8 tie Thursday.&#nlDespite that result, the FDA is expected to decide by..."
  ["description"]=>
  string(252) "FRIDAY, Jan. 18, 2019 -- A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for type 1 diabetes ended in an 8-8 tie Thursday.&#nlDespite that result, the FDA is expected to decide by..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(174) "https://www.drugs.com/news/fda-panel-has-tie-vote-new-type-1-diabetes-79847.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Panel+Has+Tie+Vote+on+New+Type+1+Diabetes+Drug"
  ["blog_url"]=>
  string(174) "https://www.drugs.com/news/fda-panel-has-tie-vote-new-type-1-diabetes-79847.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Panel+Has+Tie+Vote+on+New+Type+1+Diabetes+Drug"
  [15]=>
  string(19) "2019-01-18 20:00:24"
  ["add_date"]=>
  string(19) "2019-01-18 20:00:24"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

FDA Panel Has Tie Vote on New Type 1 Diabetes Drug

FRIDAY, Jan. 18, 2019 -- A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the

array(40) {
  [0]=>
  string(4) "1624"
  ["article_id"]=>
  string(4) "1624"
  [1]=>
  string(42) "Melanoma Survival Varies Among U.S. States"
  ["article_title"]=>
  string(42) "Melanoma Survival Varies Among U.S. States"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- U.S. states with more physicians and a larger percentage of non-Hispanic whites have worse melanoma survival, according to a "
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- U.S. states with more physicians and a larger percentage of non-Hispanic whites have worse melanoma survival, according to a "
  [3]=>
  string(252) "FRIDAY, Jan. 18, 2019 -- U.S. states with more physicians and a larger percentage of non-Hispanic whites have worse melanoma survival, according to a study published online Jan. 16 in the Journal of the American Academy of Dermatology.&#nlZachary H...."
  ["description"]=>
  string(252) "FRIDAY, Jan. 18, 2019 -- U.S. states with more physicians and a larger percentage of non-Hispanic whites have worse melanoma survival, according to a study published online Jan. 16 in the Journal of the American Academy of Dermatology.&#nlZachary H...."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(165) "https://www.drugs.com/news/melanoma-survival-varies-among-u-s-states-79840.html?utm_source=ddc&utm_medium=rss&utm_campaign=Melanoma+Survival+Varies+Among+U.S.+States"
  ["blog_url"]=>
  string(165) "https://www.drugs.com/news/melanoma-survival-varies-among-u-s-states-79840.html?utm_source=ddc&utm_medium=rss&utm_campaign=Melanoma+Survival+Varies+Among+U.S.+States"
  [15]=>
  string(19) "2019-01-18 20:00:17"
  ["add_date"]=>
  string(19) "2019-01-18 20:00:17"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Melanoma Survival Varies Among U.S. States

FRIDAY, Jan. 18, 2019 -- U.S. states with more physicians and a larger percentage of non-Hispanic whites have worse mela

array(40) {
  [0]=>
  string(4) "1625"
  ["article_id"]=>
  string(4) "1625"
  [1]=>
  string(71) "FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents"
  ["article_title"]=>
  string(71) "FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- The U.S. Food and Drug Administration alerted health care providers on Thursday that the agency is investigating the use of p"
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- The U.S. Food and Drug Administration alerted health care providers on Thursday that the agency is investigating the use of p"
  [3]=>
  string(251) "FRIDAY, Jan. 18, 2019 -- The U.S. Food and Drug Administration alerted health care providers on Thursday that the agency is investigating the use of paclitaxel-coated balloons and paclitaxel-eluting stents to treat peripheral arterial disease (PAD)..."
  ["description"]=>
  string(251) "FRIDAY, Jan. 18, 2019 -- The U.S. Food and Drug Administration alerted health care providers on Thursday that the agency is investigating the use of paclitaxel-coated balloons and paclitaxel-eluting stents to treat peripheral arterial disease (PAD)..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(225) "https://www.drugs.com/news/fda-investigating-paclitaxel-coated-balloons-paclitaxel-eluting-stents-79846.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Investigating+Paclitaxel-Coated+Balloons%2C+Paclitaxel-Eluting+Stents"
  ["blog_url"]=>
  string(225) "https://www.drugs.com/news/fda-investigating-paclitaxel-coated-balloons-paclitaxel-eluting-stents-79846.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Investigating+Paclitaxel-Coated+Balloons%2C+Paclitaxel-Eluting+Stents"
  [15]=>
  string(19) "2019-01-18 20:00:16"
  ["add_date"]=>
  string(19) "2019-01-18 20:00:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

FDA Investigating Paclitaxel-Coated Balloons, Paclitaxel-Eluting Stents

FRIDAY, Jan. 18, 2019 -- The U.S. Food and Drug Administration alerted health care providers on Thursday that the agency

array(40) {
  [0]=>
  string(4) "1626"
  ["article_id"]=>
  string(4) "1626"
  [1]=>
  string(59) "Mandated Neonatal Abstinence Reporting Helps Quantify Cases"
  ["article_title"]=>
  string(59) "Mandated Neonatal Abstinence Reporting Helps Quantify Cases"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- Mandated neonatal abstinence syndrome (NAS) surveillance and reporting allows state health departments to quantify incidence "
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- Mandated neonatal abstinence syndrome (NAS) surveillance and reporting allows state health departments to quantify incidence "
  [3]=>
  string(252) "FRIDAY, Jan. 18, 2019 -- Mandated neonatal abstinence syndrome (NAS) surveillance and reporting allows state health departments to quantify incidence and informs programs and services, according to research published in the Jan. 11 issue of the U.S...."
  ["description"]=>
  string(252) "FRIDAY, Jan. 18, 2019 -- Mandated neonatal abstinence syndrome (NAS) surveillance and reporting allows state health departments to quantify incidence and informs programs and services, according to research published in the Jan. 11 issue of the U.S...."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(200) "https://www.drugs.com/news/mandated-neonatal-abstinence-reporting-helps-quantify-cases-79839.html?utm_source=ddc&utm_medium=rss&utm_campaign=Mandated+Neonatal+Abstinence+Reporting+Helps+Quantify+Cases"
  ["blog_url"]=>
  string(200) "https://www.drugs.com/news/mandated-neonatal-abstinence-reporting-helps-quantify-cases-79839.html?utm_source=ddc&utm_medium=rss&utm_campaign=Mandated+Neonatal+Abstinence+Reporting+Helps+Quantify+Cases"
  [15]=>
  string(19) "2019-01-18 20:00:11"
  ["add_date"]=>
  string(19) "2019-01-18 20:00:11"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Mandated Neonatal Abstinence Reporting Helps Quantify Cases

FRIDAY, Jan. 18, 2019 -- Mandated neonatal abstinence syndrome (NAS) surveillance and reporting allows state health depa

array(40) {
  [0]=>
  string(4) "1627"
  ["article_id"]=>
  string(4) "1627"
  [1]=>
  string(65) "Radiographic Knee Osteoarthritis Tied to Increased Risk for Death"
  ["article_title"]=>
  string(65) "Radiographic Knee Osteoarthritis Tied to Increased Risk for Death"
  [2]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- Radiographic knee osteoarthritis (RKOA) is associated with an increased risk for mortality from cardiovascular disease (CVD),"
  ["short_description"]=>
  string(150) "FRIDAY, Jan. 18, 2019 -- Radiographic knee osteoarthritis (RKOA) is associated with an increased risk for mortality from cardiovascular disease (CVD),"
  [3]=>
  string(250) "FRIDAY, Jan. 18, 2019 -- Radiographic knee osteoarthritis (RKOA) is associated with an increased risk for mortality from cardiovascular disease (CVD), diabetes, and renal diseases, but self-reported OA is not, according to a study published in the..."
  ["description"]=>
  string(250) "FRIDAY, Jan. 18, 2019 -- Radiographic knee osteoarthritis (RKOA) is associated with an increased risk for mortality from cardiovascular disease (CVD), diabetes, and renal diseases, but self-reported OA is not, according to a study published in the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(205) "https://www.drugs.com/news/radiographic-knee-osteoarthritis-tied-increased-risk-death-79838.html?utm_source=ddc&utm_medium=rss&utm_campaign=Radiographic+Knee+Osteoarthritis+Tied+to+Increased+Risk+for+Death"
  ["blog_url"]=>
  string(205) "https://www.drugs.com/news/radiographic-knee-osteoarthritis-tied-increased-risk-death-79838.html?utm_source=ddc&utm_medium=rss&utm_campaign=Radiographic+Knee+Osteoarthritis+Tied+to+Increased+Risk+for+Death"
  [15]=>
  string(19) "2019-01-18 20:00:09"
  ["add_date"]=>
  string(19) "2019-01-18 20:00:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Radiographic Knee Osteoarthritis Tied to Increased Risk for Death

FRIDAY, Jan. 18, 2019 -- Radiographic knee osteoarthritis (RKOA) is associated with an increased risk for mortality from

array(40) {
  [0]=>
  string(4) "1583"
  ["article_id"]=>
  string(4) "1583"
  [1]=>
  string(37) "NICE OK for Bravtovi skin cancer drug"
  ["article_title"]=>
  string(37) "NICE OK for Bravtovi skin cancer drug"
  [2]=>
  string(150) "The National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi and Mektovi combination as an option for so"
  ["short_description"]=>
  string(150) "The National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi and Mektovi combination as an option for so"
  [3]=>
  string(174) "The National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi and Mektovi combination as an option for some people with melanoma."
  ["description"]=>
  string(174) "The National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi and Mektovi combination as an option for some people with melanoma."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(77) "http://www.pharmatimes.com/news/nice_ok_for_bravtovi_skin_cancer_drug_1275652"
  ["blog_url"]=>
  string(77) "http://www.pharmatimes.com/news/nice_ok_for_bravtovi_skin_cancer_drug_1275652"
  [15]=>
  string(19) "2019-01-18 19:44:20"
  ["add_date"]=>
  string(19) "2019-01-18 19:44:20"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

NICE OK for Bravtovi skin cancer drug

The National Institute for Health and Care Excellence (NICE) has recommended Pierre Fabre’s Bravtovi and Mektovi c

array(40) {
  [0]=>
  string(4) "1584"
  ["article_id"]=>
  string(4) "1584"
  [1]=>
  string(35) "Janssen to use Apple watch for AFib"
  ["article_title"]=>
  string(35) "Janssen to use Apple watch for AFib"
  [2]=>
  string(150) "Johnson & Johnson’s Janssen has announced a research study using the Apple watch to help improve atrial fibrillation (AFib) outcomes, includ"
  ["short_description"]=>
  string(150) "Johnson & Johnson’s Janssen has announced a research study using the Apple watch to help improve atrial fibrillation (AFib) outcomes, includ"
  [3]=>
  string(330) "Johnson & Johnson’s Janssen has announced a research study using the Apple watch to help improve atrial fibrillation (AFib) outcomes, including stroke prevention, intending to to collaborate with Apple to assess the impact of the wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes."
  ["description"]=>
  string(330) "Johnson & Johnson’s Janssen has announced a research study using the Apple watch to help improve atrial fibrillation (AFib) outcomes, including stroke prevention, intending to to collaborate with Apple to assess the impact of the wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(75) "http://www.pharmatimes.com/news/janssen_to_use_apple_watch_for_afib_1275622"
  ["blog_url"]=>
  string(75) "http://www.pharmatimes.com/news/janssen_to_use_apple_watch_for_afib_1275622"
  [15]=>
  string(19) "2019-01-18 19:42:35"
  ["add_date"]=>
  string(19) "2019-01-18 19:42:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Janssen to use Apple watch for AFib

Johnson & Johnson’s Janssen has announced a research study using the Apple watch to help improve atrial fibril

array(40) {
  [0]=>
  string(4) "1585"
  ["article_id"]=>
  string(4) "1585"
  [1]=>
  string(51) "Positive results for UB-311 Alzheimer's vaccine"
  ["article_title"]=>
  string(51) "Positive results for UB-311 Alzheimer's vaccine"
  [2]=>
  string(154) "United Neuroscience has announced a positive top-line results from the Phase IIa clinical study of UB-311 vaccine in patients with Alzheimer's disease"
  ["short_description"]=>
  string(154) "United Neuroscience has announced a positive top-line results from the Phase IIa clinical study of UB-311 vaccine in patients with Alzheimer's disease"
  [3]=>
  string(155) "United Neuroscience has announced a positive top-line results from the Phase IIa clinical study of UB-311 vaccine in patients with Alzheimer's disease."
  ["description"]=>
  string(155) "United Neuroscience has announced a positive top-line results from the Phase IIa clinical study of UB-311 vaccine in patients with Alzheimer's disease."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(86) "http://www.pharmatimes.com/news/positive_results_for_ub-311_alzheimers_vaccine_1275579"
  ["blog_url"]=>
  string(86) "http://www.pharmatimes.com/news/positive_results_for_ub-311_alzheimers_vaccine_1275579"
  [15]=>
  string(19) "2019-01-18 19:35:54"
  ["add_date"]=>
  string(19) "2019-01-18 19:35:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Positive results for UB-311 Alzheimer's vaccine

United Neuroscience has announced a positive top-line results from the Phase IIa clinical study of UB-311 vaccine in pat

array(40) {
  [0]=>
  string(4) "1586"
  ["article_id"]=>
  string(4) "1586"
  [1]=>
  string(63) "Venetoclax gets NICE approval for chronic lymphocytic leukaemia"
  ["article_title"]=>
  string(63) "Venetoclax gets NICE approval for chronic lymphocytic leukaemia"
  [2]=>
  string(150) "The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Venclyxto to benefit thousands of adults with chronic lymp"
  ["short_description"]=>
  string(150) "The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Venclyxto to benefit thousands of adults with chronic lymp"
  [3]=>
  string(168) "The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Venclyxto to benefit thousands of adults with chronic lymphocytic leukaemia."
  ["description"]=>
  string(168) "The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Venclyxto to benefit thousands of adults with chronic lymphocytic leukaemia."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(103) "http://www.pharmatimes.com/news/venetoclax_gets_nice_approval_for_chronic_lymphocytic_leukaemia_1275569"
  ["blog_url"]=>
  string(103) "http://www.pharmatimes.com/news/venetoclax_gets_nice_approval_for_chronic_lymphocytic_leukaemia_1275569"
  [15]=>
  string(19) "2019-01-18 19:34:34"
  ["add_date"]=>
  string(19) "2019-01-18 19:34:34"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Venetoclax gets NICE approval for chronic lymphocytic leukaemia

The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s Venclyxto to benefit thousan

array(40) {
  [0]=>
  string(4) "1587"
  ["article_id"]=>
  string(4) "1587"
  [1]=>
  string(86) "Novartis and Uni of Oxford to join forces and use AI for diseases and drug development"
  ["article_title"]=>
  string(86) "Novartis and Uni of Oxford to join forces and use AI for diseases and drug development"
  [2]=>
  string(150) "Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using artific"
  ["short_description"]=>
  string(150) "Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using artific"
  [3]=>
  string(227) "Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using artificial intelligence to understand complex diseases and improve drug development."
  ["description"]=>
  string(227) "Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year research alliance using artificial intelligence to understand complex diseases and improve drug development."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(126) "http://www.pharmatimes.com/news/novartis_and_uni_of_oxford_to_join_forces_and_use_ai_for_diseases_and_drug_development_1275546"
  ["blog_url"]=>
  string(126) "http://www.pharmatimes.com/news/novartis_and_uni_of_oxford_to_join_forces_and_use_ai_for_diseases_and_drug_development_1275546"
  [15]=>
  string(19) "2019-01-18 19:32:52"
  ["add_date"]=>
  string(19) "2019-01-18 19:32:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Novartis and Uni of Oxford to join forces and use AI for diseases and drug development

Novartis and the University of Oxford’s Big Data Institute have announced that they are to establish a five-year r

array(40) {
  [0]=>
  string(4) "1601"
  ["article_id"]=>
  string(4) "1601"
  [1]=>
  string(34) "Frailty a Risk Factor for Dementia"
  ["article_title"]=>
  string(34) "Frailty a Risk Factor for Dementia"
  [2]=>
  string(161) "FRIDAY, Jan. 18, 2019 -- Frailty is associated with a higher risk of both Alzheimer's disease and its crippling symptoms, a new study shows.&#nl"By reduc"
  ["short_description"]=>
  string(161) "FRIDAY, Jan. 18, 2019 -- Frailty is associated with a higher risk of both Alzheimer's disease and its crippling symptoms, a new study shows.&#nl"By reduc"
  [3]=>
  string(259) "FRIDAY, Jan. 18, 2019 -- Frailty is associated with a higher risk of both Alzheimer's disease and its crippling symptoms, a new study shows.&#nl"By reducing an individual's physiological reserve, frailty could trigger the clinical expression of..."
  ["description"]=>
  string(259) "FRIDAY, Jan. 18, 2019 -- Frailty is associated with a higher risk of both Alzheimer's disease and its crippling symptoms, a new study shows.&#nl"By reducing an individual's physiological reserve, frailty could trigger the clinical expression of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(144) "https://www.drugs.com/news/frailty-risk-factor-dementia-79828.html?utm_source=ddc&utm_medium=rss&utm_campaign=Frailty+a+Risk+Factor+for+Dementia"
  ["blog_url"]=>
  string(144) "https://www.drugs.com/news/frailty-risk-factor-dementia-79828.html?utm_source=ddc&utm_medium=rss&utm_campaign=Frailty+a+Risk+Factor+for+Dementia"
  [15]=>
  string(19) "2019-01-18 17:01:46"
  ["add_date"]=>
  string(19) "2019-01-18 17:01:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Frailty a Risk Factor for Dementia

FRIDAY, Jan. 18, 2019 -- Frailty is associated with a higher risk of both Alzheimer's disease and its crippling symp